laboratori
focus
studi
molecular
regul
lymphocyt
homeostasi
particularli
relat
immunolog
toler
apoptosi
autoimmun
diseas
intens
molecular
research
regul
lymphocyt
fate
fa
receptor
tumor
necrosi
factor
receptor
well
ligand
emerg
key
regul
lymphocyt
apoptosi
studi
genet
abnorm
death
pathway
particularli
context
autoimmun
lymphoprolif
syndrom
alp
nonalp
condit
avect
lymphocyt
homeostasi
studi
led
investig
regul
nfb
signal
pathway
molecular
basi
program
cell
death
viral
cytopath
mechan
autoimmun
regul
matur
tcell
toler
investig
promis
provid
insight
molecular
mechan
behind
regul
immun
respons
contribut
develop
novel
diagnost
treatment
method
autoimmun
diseas
classiw
alp
patient
sever
genet
subtyp
type
iamut
fa
receptor
essenti
alway
heterozyg
dominantinterf
patient
type
ibmut
fa
ligand
heterozyg
also
dominantinterf
patient
type
iimut
heteroor
homozyg
patient
type
iiiundewn
genet
alter
patient
type
ivactiv
mutat
nra
heterozyg
discoveri
famili
homozyg
mutat
pose
interest
scientiwc
puzzl
would
expect
patient
similar
type
ii
patient
howev
exhibit
minor
elev
characterist
dnt
cell
manifest
profound
immunodewci
extens
workup
earli
signal
event
show
dewcienc
speciwc
abolish
nfb
activ
due
antigen
receptor
stimul
b
lymphocyt
fc
receptor
stimul
natur
killer
nk
cell
fig
discov
caus
ikappab
kinas
ikk
complex
associ
cbm
complex
form
nfbactiv
holoenzym
ikk
recruit
phosphoryl
well
nfb
nuclear
transloc
requir
enzym
activ
fulllength
experi
establish
function
pivot
molecul
death
receptor
signal
also
key
role
nfb
induct
antigen
fc
receptor
interestingli
subserv
two
diver
function
lymphocyt
adopt
diver
molecular
form
diver
function
context
discoveri
base
singl
famili
extens
search
around
world
anoth
famili
unsuccess
went
conwrm
human
observ
subsequ
experi
collabor
use
condit
knockout
lymphocyt
mice
studi
project
aim
elucid
substrat
immunoreceptor
signal
character
new
gene
defect
genet
abnorm
immun
homeostasi
also
conduct
molecular
analys
fa
death
receptor
alp
type
ia
patient
indic
patient
harbor
mutat
cytoplasm
death
domain
prevent
assembl
deathinduc
signal
complex
disc
failur
disc
format
account
lack
apoptosi
induct
howev
intrigu
exampl
death
domain
mutat
still
allow
format
normal
signal
complex
yet
still
fail
produc
apoptot
respons
cell
therefor
initi
cell
biolog
studi
receptor
cell
surfac
reveal
key
featur
fig
nuclear
transloc
nfb
defect
dewcienc
syndrom
ced
confoc
microscopi
photomicrograph
peripher
blood
lymphocyt
normal
control
n
unavect
mother
two
avect
sibl
either
stimul
none
follow
stimul
mcg
per
ml
h
cell
prepar
stain
subunit
nfb
green
hoeschst
dye
nuclear
dna
red
coincid
stain
yellow
cell
nfb
transloc
nucleu
coincid
stain
nuclear
transloc
defect
none
signal
transduct
later
associ
ligand
receptor
larg
assembl
involv
thousand
receptor
trimer
could
visual
microscop
term
higher
order
assembl
signal
protein
oligomer
transduct
structur
spot
speciwc
alp
case
determin
mutat
death
domain
prevent
spot
format
therebi
explain
defect
signal
function
thu
studi
atyp
alp
fa
mutant
reveal
crucial
signal
step
recogn
previous
anoth
fruit
line
investig
studi
patient
cardin
featur
alp
gene
mutat
compon
fa
pathway
one
group
patient
show
defect
apoptosi
fa
stimul
patient
fascin
puzzl
infer
alter
complet
diver
death
pathway
interrog
intrins
mitochondri
mechan
apoptosi
regul
famili
member
one
patient
sampl
male
manifest
autoimmun
chronic
lymphadenopathi
increas
dnt
cell
biochem
analys
reveal
decreas
level
bim
proapoptot
member
famili
gene
express
microarray
combin
bioinformat
analysi
pinpoint
defect
nrasa
gene
previous
implic
autoimmun
molecular
analysi
reveal
heterozyg
germlin
activ
mutat
nra
oncogen
impair
apoptosi
found
increas
activ
gtpbound
nra
augment
rafmekerk
signal
decreas
proapoptot
protein
bim
inhibit
mitochondri
apoptosi
rnai
knockdown
mutant
nra
rescu
apoptosi
patient
cell
wherea
express
mutant
allel
normal
lymphocyt
recapitul
patient
apoptosi
evect
data
show
nra
mutat
princip
avect
apoptosi
pathway
predispos
cancer
disrupt
lymphocyt
homeostasi
toler
final
investig
heterozyg
mutat
fa
ligand
fasl
caus
defect
cell
kill
alp
studi
alp
type
ib
patient
heterozyg
fasl
gene
mutat
replac
arg
gli
posit
extracellular
receptorbind
region
protein
found
mutant
protein
associ
normal
wildtyp
protein
sinc
fasl
homotrimer
symmetri
fa
mix
complex
format
produc
nonstimulatori
homotrim
dominantli
interf
apoptosi
heterozyg
fasl
mutat
patient
intrigu
question
aros
lab
regard
extens
role
gene
regul
carri
nfb
sinc
wrst
function
studi
nfb
liter
hundr
gene
shown
control
nfb
nevertheless
pattern
gene
regul
often
speciwc
stimulu
therefor
initi
experi
understand
regulatori
speciwc
perform
simpl
experi
rel
subunit
nfb
complex
use
tandem
ayniti
puriwc
mass
spectrometri
proteom
screen
identifi
tightli
associ
protein
perhap
biggest
surpris
research
discoveri
third
nonrel
subunit
intrins
part
nfb
dnabind
complex
third
subunit
member
famili
k
homolog
kh
domain
protein
confer
speciwc
bind
speciwc
nucleotid
version
otherwis
degener
dnabind
site
discoveri
wrst
new
subunit
nfb
year
suggest
diver
nfb
complex
nucleu
masquerad
singl
dnabind
complex
also
found
sever
new
compon
signal
transduct
complex
antigen
receptor
provid
new
understand
signal
transmit
futur
work
address
mechan
confer
genespeciwc
nfb
regul
identiwc
addit
subunit
control
nfb
target
thu
far
preliminari
result
identiw
kh
domain
protein
serv
addit
subunit
nfb
major
focu
work
virus
uncov
molecular
basi
cytopath
evect
uncov
viral
function
requir
cell
death
systemat
mutat
alon
combin
open
read
frame
strain
hiv
type
elimin
vif
vpr
accessori
gene
togeth
alon
block
viral
cell
death
g
cell
cycl
arrest
converg
two
cellular
event
rais
theoret
problem
explan
loss
cell
therefor
construct
mathemat
model
viral
dynam
vitro
term
three
evect
timedepend
rate
cell
prolifer
infect
death
use
mathemat
model
viral
dynam
vitro
could
show
viabl
target
cell
predominantli
deplet
direct
cell
death
rather
cell
cycl
blockad
vif
vpr
accessori
gene
caus
g
arrest
cell
death
believ
intim
relat
examin
molecular
mechan
cell
cycl
blockad
wnding
may
provid
import
insight
molecular
mechan
viral
pathogenesi
aid
understand
caus
cell
cycl
arrest
cell
death
necrosi
quantit
measur
infect
tissu
cultur
use
xow
cytometri
viral
encod
marker
protein
heatstabl
antigen
hsa
discov
hsa
appear
surfac
target
cell
two
phase
passiv
acquisit
due
associ
fusion
virion
target
cell
follow
activ
protein
express
transcript
integr
proviru
latter
event
obligatori
step
lead
decreas
target
cell
viabil
use
mathemat
model
vitro
viral
dynam
base
sever
timedepend
factor
show
predomin
contribut
deplet
viabl
target
cell
result
direct
cell
death
rather
cell
cycl
blockad
infer
death
rate
hivinfect
cell
time
greater
uninfect
cell
elimin
vpr
protein
reduc
death
rate
half
approach
provid
new
method
estim
timedepend
death
rate
associ
viru
infect
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
emerg
new
pathogen
caus
debilit
pneumonia
infect
destruct
airway
cell
sar
potenti
global
health
threat
littl
known
particular
coronaviru
highli
lethal
human
collabor
kanta
subbarao
lidniaid
therefor
investig
viral
cytotox
compon
mechan
cell
kill
found
sarscov
induc
promin
nonapoptot
cell
death
disrupt
golgi
apparatu
cell
death
depend
express
one
novel
open
read
frame
present
sarscov
found
human
coronavirus
overexpress
golgiassoci
protein
stabil
golgi
structur
function
rescu
virusinfect
cell
death
restor
golgi
integr
found
vaccinia
viru
poxviru
unrel
sarscov
also
caus
golgi
disintegr
cell
death
bernard
moss
lvdniaid
show
vaccinia
protein
respons
evect
singl
amino
acid
substitut
abolish
abil
caus
golgimedi
cytopath
thu
result
dewn
virusinduc
golgi
disintegr
induc
varieti
diver
virus
includ
polioviru
cytotox
event
could
modiw
use
golgistabil
drug
also
attempt
better
dewn
molecular
pathway
caus
nonapoptot
cell
death
nonapoptot
program
cell
death
conwrm
autophagi
inde
lead
program
cell
death
also
dewn
molecular
pathway
receptorinteract
protein
rip
lead
jun
ntermin
kinas
activ
induc
cell
death
autophagi
use
gene
knockdown
show
autophag
death
requir
gene
strongli
promot
inhibit
thu
regul
ancient
nonapoptot
cell
death
pathway
involv
autophagi
also
consid
two
major
hypothes
explain
autophag
deatheith
cell
eat
much
eat
wrong
thing
molecular
examin
zvadinduc
autophag
death
reveal
catalas
select
degrad
conwrm
notion
cell
eat
protein
caus
advers
consequ
result
reactiv
oxygen
speci
ro
accumul
membran
lipid
oxid
loss
plasma
membran
integr
lead
necrosi
inhibit
autophagi
chemic
compound
knock
express
key
autophagi
protein
block
ro
accumul
cell
death
caus
abnorm
ro
accumul
select
autophag
degrad
major
enzymat
ro
scaveng
catalas
wnding
unveil
molecular
mechan
role
autophagi
cell
death
provid
insight
complex
relationship
ro
nonapoptot
program
cell
death
clinic
therapi
involv
caspas
inhibitor
may
arrest
apoptosi
may
unanticip
evect
promot
autophag
cell
death
ro
toxic
plan
delv
molecular
basi
diverenti
util
autophagi
cell
surviv
cell
death
one
protein
attract
interest
hspinth
human
ortholog
drosophila
melanogast
gene
spinster
pursu
gene
found
knock
hspin
prevent
autophag
death
gener
process
autophagi
experi
may
shed
light
molecular
distinct
surviv
autophagi
autophag
cell
death
discoveri
preligand
assembl
domain
plad
domain
variou
member
tnfr
superfamili
especi
tnfr
prompt
us
carri
preclin
studi
arthriti
develop
biopharmaceut
autoimmun
diseas
tumor
necrosi
factoralpha
tnf
import
role
pathogenesi
autoimmun
inxammatori
diseas
rheumatoid
septic
arthriti
tnf
blocker
etanercept
enbrel
inxiximab
remicad
remark
success
pharmaceut
agent
highli
evect
amelior
rheumatoid
arthriti
crohn
diseas
respect
seriou
complic
mycobacteri
infect
sinc
pathogen
evect
tnf
arthriti
mainli
due
studi
evect
solubl
version
plad
gst
fusion
protein
vitro
vivo
found
protein
block
cellular
evect
tnf
vitro
potent
inhibit
arthriti
four
diver
anim
model
thu
pladbas
therapeut
may
clinic
valu
treatment
human
arthritid
diseas
involv
tnfr
superfamili
receptor
plan
partner
pharmaceut
compani
make
clinic
use
version
plad
protein
monoclon
antibodi
could
use
plad
antagonist
also
plan
develop
plad
antagonist
tnfr
superfamili
member
clinic
import
bli
receptor
develop
sound
basi
antigenspeciwc
cell
delet
therapi
autoimmun
diseas
possibl
allerg
condit
graft
reject
pursu
two
object
earli
detect
autoimmun
process
simpliw
antigen
system
treatment
earli
detect
import
clinic
autoimmun
diseas
becom
appar
may
alreadi
signiwc
damag
end
organ
simpliw
antigen
system
import
antigendirect
therapi
address
correct
lymphocyt
speciwc
multipl
sclerosi
controversi
relev
antigen
target
pathogen
immun
respons
moreov
new
speciwc
uncov
epitop
spread
document
new
cooper
research
develop
agreement
wellstat
biolog
investig
earli
detect
simpliw
antigen
system
two
diseas
set
develop
inhibitori
antibodi
factor
viii
treatment
sever
hemophilia
type
diabet
lack
toler
hemophiliac
permit
immun
respons
foster
develop
switch
igg
antibodi
factor
viii
impair
function
coagul
sinc
epitop
contain
singl
protein
present
ideal
target
scientist
wellstat
done
pioneer
work
electrochemiluminesc
ecl
especi
use
antibodi
detect
plasma
develop
highli
sensit
speciwc
test
may
use
mice
human
detect
inhibitori
antibodi
factor
viii
insulin
autoantibodi
iaa
type
diabet
nod
mous
experi
iaa
test
detect
mice
becom
diabet
high
speciwc
nonradioact
test
perform
h
wherea
current
use
radioimmunoassay
take
h
requir
radiolabel
reagent
work
wellstat
biolog
extend
two
direct
clinic
diagnost
test
establish
collabor
test
upcom
human
clinic
trial
therapi
process
prepar
variou
tolerogen
protein
plan
prepar
mammalian
e
coli
express
construct
four
princip
candid
protein
identiw
target
antigen
type
diabet
insulin
gad
use
develop
therapeut
ecl
test
well
preclin
experi
delet
toler
key
issu
mammalian
immunolog
cell
treg
cell
suppress
immun
respons
suppress
evect
treg
cell
extens
discuss
fate
evector
cell
quantit
examin
vivo
vitro
therefor
undertook
line
experiment
address
involv
apoptosi
treg
suppress
evect
found
treg
cell
induc
apoptosi
evector
cell
quantit
account
suppress
evect
variou
vitro
assay
also
show
treg
cell
avect
earli
activ
particularli
gene
transcript
prolifer
evector
cell
respons
tcr
stimul
rather
treg
cell
induc
evector
cell
death
due
consumpt
surviv
cytokin
produc
evector
cell
requir
proapoptot
protein
bim
also
associ
lower
activ
prosurviv
kinas
akt
less
phosphoryl
proapoptot
protein
bad
evect
nulliw
ad
back
surviv
cytokin
typic
util
common
gamma
chain
receptor
thu
high
level
express
surviv
cytokin
receptor
treg
coupl
fact
consum
produc
surviv
cytokin
caus
induc
cytokin
depriv
apoptosi
evector
cell
found
cytokin
consumpt
essenti
surviv
treg
cell
also
document
promin
apoptosi
evector
cell
vivo
mous
model
inxammatori
bowel
diseas
therefor
cytokin
deprivationinduc
apoptosi
key
mechan
treg
cell
suppress
evector
cell
respons
work
address
physiolog
role
interact
variou
cell
subset
especi
treg
h
cell
